Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06062056 · ClinicalTrials.gov registry record · NA
Motivational Interviewing for Vaccine Uptake in Latinx Adults
A NA study, sponsored by Boston College.
- Terminated
- Registry status
- NA
- Development phase
- 3,698
- Enrollment target
NCT06062056: Clinical Trial NA study, sponsored by Boston College.
NCT06062056 is a NA study that was terminated before completion, run by Boston College. The registered enrollment target is 3,698 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (163% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06062056, a NA study, was terminated before completion, sponsored by Boston College.
- TERMINATED
- Registry status
- NA
- Development phase
- 3,698 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test whether modified behavioral health services, integrating motivational interviewing, will reduce vaccine hesitancy and increase uptake for the COVID-19 and influenza vaccines among Latinx adults with mental illness.
Primary Outcome
Binary indicator extracted from EHR
Interventions
- BEHAVIORAL Motivational Interviewing
- OTHER EHR alert
- BEHAVIORAL Warm hand off to nurse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,698 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Why NCT06062056 stopped before completion
NCT06062056 is an interventional study that assigns participants to a tested intervention. Its 3,698 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (163% higher).
The record links to 0 conditions, and to 3 interventions - of which Motivational Interviewing is the first listed.
NCT06062056 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06062056 about?
NCT06062056 is a clinical study titled "Motivational Interviewing for Vaccine Uptake in Latinx Adults". The goal of this clinical trial is to test whether modified behavioral health services, integrating motivational interviewing, will reduce vaccine hesitancy and increase uptake for the COVID-19 and influenza vaccines among Latinx adults with mental illness.
What is the current status of trial NCT06062056?
This trial is currently terminated. It is a NA study. The enrollment target is 3,698 participants. The study started on 2023-10-02. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06062056?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), EHR alert (OTHER), Warm hand off to nurse (BEHAVIORAL).
Who is sponsoring clinical trial NCT06062056?
This trial is sponsored by Boston College, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06062056's enrollment target sits among peer trials
3,698 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06401863 · 3,691 participants · NA
Shared Decision for Drug Interactions in Oral Anticoagulation
- NCT06784960 · 3,689 participants · NA
Communication Strategies to Increase HPV Vaccination Intention
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI